在临床前的模型中,催产素治疗减少了癌症缓解症
Alexandra Sviercovich1, Etsuko Watanabe2, Estefania S Fernandez3
1DAHFMO Unit of Histology and Medical Embryology, and Interuniversity Institute of Myology, Sapienza University of Rome, Italy; Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8263, Inserm U1345, Development, Adaptation and Ageing (Dev2A), Paris, France; Dept. Of Bioengineering, QB3, Stanley Hall, University of California, Berkeley, USA.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|November 26, 2025
概括
催产素 (OT) 水平在癌症患者和肉肌肌肉中较低. 在临床前的模型中,补充OT可以逆转肌肉损失和改善蛋白质合成,这表明它对癌症缓解症的治疗潜力.
科学领域:
- 内分泌学 在内分泌学.
- 肌肉生理学 肌肉生理学
- 在瘤学瘤学.
背景情况:
- 催产素 (OT) 对于骨肌肉平衡至关重要,并对抗与年龄相关的肌肉损失 (肉症).
- 在癌症缓冲症中,OT在癌症缓冲症中的作用,这是一种以肌肉消耗为特征的衰弱状况,仍然在很大程度上是未知的.
研究的目的:
- 为了研究癌症患者的OT血清水平及其在sarcopenic肌肉中的表达.
- 评估OT在癌症缓解症的临床前模型中的治疗潜力.
主要方法:
- 测量了癌症患者,卡赫西克患者和对照患者的血清OT水平.
- 在sarcopenic肌肉中评估的OT/OT-受体 (OTR) mRNA.
- 在体外 (肌细胞,肌纤维) 和体内 (癌症缓解模型) 调查的OT效应.
- 使用BONCAT分析了蛋白质合成的分子效应.
主要成果:
- 癌症患者的循环OT水平显著降低.
- 萨尔科佩尼克肌肉显示OTR mRNA表达减少.
- 在体外,OT抵消了瘤诱导的肌原抑制.
- 在体内,OT恢复了肌肉质量,纤维大小和体重,同时降低了肌肉降解标志物 (MuRF1,Atrogin1).
- OT正常化了癌症扰乱的蛋白质合成途径.
结论:
- 减少的催产素和OTR表达与癌症缓解症有关.
- 催产素在抵消癌症肌肉消耗方面显示出显著的治疗潜力.
- 由于其现有的临床批准,催产素可能为癌症缓解症提供一种易于翻译的治疗方法.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


